Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
cAMP-regulated phosphoprotein 19
(ARPP-19) plays a key role in cell mitotic G2/M transition. Expression of ARPP-19 was increased in human
hepatocellular carcinoma
(
HCC
) compared to adjacent non-tumorous liver tissues in 36 paired liver samples, and the level of ARPP-19 in
HCC
tissues was positively correlated with the tumor size. To determine the interrelationship between ARPP-19 expression and
HCC
, we silenced ARPP-19 expression in the human
hepatocarcinoma
HepG2 and SMMC-7721 cells using lentivirus encoding ARPP-19 siRNA. HepG2 and SMMC-7721 cells with ARPP-19 knockdown displayed lowered cell growth rate, retarded colony formation and increased arrest at the G2/M phase transition. Silencing ARPP-19 in
HCC
cells resulted in decreased protein levels of phospho-(Ser) CDKs substrates and increased levels of inactivated cyclin division cycle 2 (Cdc2). Therefore, ARPP-19 may play a role in
HCC
pathogenesis through regulating cell proliferation.
...
PMID:Increased ARPP-19 expression is associated with hepatocellular carcinoma. 2554 87